gp120 Immunogen Design And Characterization
HIV-1 is the causative agent for AIDS and has been a major focus of research for the past two decades. Though there is a combination therapy in place known as the “Highly Active Anti-Retroviral Therapy” (HAART), its usefulness is confounded by the generation of escape mutants, a host of side effects...
Main Author: | Chakraborty, Kausik |
---|---|
Other Authors: | Varadarajan, Raghavan |
Language: | en_US |
Published: |
2011
|
Subjects: | |
Online Access: | http://etd.iisc.ernet.in/handle/2005/1499 http://etd.ncsi.iisc.ernet.in/abstracts/1920/G19945-Abs.pdf |
Similar Items
-
HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell
by: Gabriel Valentín-Guillama, et al.
Published: (2018-09-01) -
Protein Minimization Of Human CD4 And Design Of gp120-CD4 Single Chain Immunogens
by: Sharma, Deepak Kumar
Published: (2011) -
The expression, purification and characterisation of recombinant HIV-1 subtype C gp120
by: Michler, Katherine Laura
Published: (2008) -
Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing Antibodies
by: Jennie M. Hutchinson, et al.
Published: (2019-05-01) -
Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 Infection
by: Xinling Wang, et al.
Published: (2021-03-01)